arXiv:2601.16449v2 Announce Type: replace-cross Abstract: Understanding human emotions from multimodal signals poses a significant challenge in affective computing and human-robot interaction. While multimodal large language models (MLLMs) have excelled in general vision-language tasks, their capabilities in emotional reasoning remain limited. The field currently suffers from a scarcity of large-scale datasets with high-quality, descriptive emotion annotations and lacks standardized benchmarks for evaluation. Our preliminary framework, Emotion-LLaMA, pioneered instruction-tuned multimodal learning for emotion reasoning but was restricted by explicit face detectors, implicit fusion strategies, and low-quality training data with limited scale. To address these limitations, we present Emotion-LLaMAv2 and the MMEVerse benchmark, establishing an end-to-end pipeline together with a standardized evaluation setting for emotion recognition and reasoning. Emotion-LLaMAv2 introduces three key advances. First, an end-to-end multiview encoder eliminates external face detection and captures nuanced emotional cues via richer spatial and temporal multiview tokens. Second, a Conv Attention pre-fusion module is designed to enable simultaneous local and global multimodal feature interactions external to the LLM backbone. Third, a perception-to-cognition curriculum instruction tuning scheme within the LLaMA2 backbone unifies emotion recognition and free-form emotion reasoning. To support large-scale training and reproducible evaluation, MMEVerse aggregates twelve publicly available emotion datasets, including IEMOCAP, MELD, DFEW, and MAFW, into a unified multimodal instruction format. The data are re-annotated via a multi-agent pipeline involving Qwen2 Audio, Qwen2.5 VL, and GPT 4o, producing 130k training clips and 36k testing clips across 18 evaluation benchmarks.

arXiv:2506.20430v3 Announce Type: replace-cross Abstract: Rare diseases affect over 300 million individuals worldwide, yet timely and accurate diagnosis remains an urgent challenge. Patients often endure a prolonged diagnostic odyssey exceeding five years, marked by repeated referrals, misdiagnoses, and unnecessary interventions, leading to delayed treatment and substantial emotional and economic burdens. Here we present DeepRare, a multi-agent system for rare disease differential diagnosis decision support powered by large language models, integrating over 40 specialized tools and up-to-date knowledge sources. DeepRare processes heterogeneous clinical inputs, including free-text descriptions, structured Human Phenotype Ontology terms, and genetic testing results, to generate ranked diagnostic hypotheses with transparent reasoning linked to verifiable medical evidence. Evaluated across nine datasets from literature, case reports and clinical centres across Asia, North America and Europe spanning 14 medical specialties, DeepRare demonstrates exceptional performance on 3,134 diseases. In human-phenotype-ontology-based tasks, it achieves an average Recall@1 of 57.18%, outperforming the next-best method by 23.79%; in multi-modal tests, it reaches 69.1% compared with Exomiser's 55.9% on 168 cases. Expert review achieved 95.4% agreement on its reasoning chains, confirming their validity and traceability. Our work not only advances rare disease diagnosis but also demonstrates how the latest powerful large-language-model-driven agentic systems can reshape current clinical workflows.